0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Prevention of Thromboembolism after Spinal Cord Injury Using Low-Molecular-Weight Heparin

David Green, MD, PhD; Michael Y. Lee, MD; Ai Chi Lim, MD; Joan S. Chmiel, PhD; Marsha Vetter, MD, PhD; Thomas Pang, MD; David Chen, MD; Lynne Fenton, MD; Gary M. Yarkony, MD; and Paul R. Meyer Jr, MD
[+] Article and Author Information

Grant Support: By grant H133B80007 from the National Institute of Disability and Rehabilitation Research, Department of Education.

Requests for Reprints: David Green, MD, PhD, 345 E. Superior Street, Room 1407, Chicago, IL 60611.

Current Author Addresses: Drs. Green, Lee, Lim, Vetter, Pang, Chen, Fenton, and Yarkony: 345 East Superior Street, Chicago, IL 60611. Dr. Chmiel: 680 North Lakeshore Drive, Suite 1104, Chicago, IL 60611. Dr. Meyer: 250 East Superior Street, Suite 619, Chicago, IL 60611.


© 1990 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1990;113(8):571-574. doi:10.7326/0003-4819-113-8-571
Text Size: A A A

Objective: To examine the safety and effectiveness of a low-molecular-weight heparin in the prevention of thromboembolism in patients with recent spinal cord injury and complete motor paralysis.

Design: Randomized evaluation of two heparin regimens in 41 consecutive patients meeting eligibility requirements for anticoagulant prophylaxis. Daily bedside examinations were supplemented by serial venous flow studies; suspicious or positive tests were confirmed by venography.

Intervention: Standard heparin, 5000 units subcutaneously three times a day; low-molecular-weight heparin 3500 anti-Xa units subcutaneously once daily.

Measurements and Main Results: Five patients in the standard heparin group had thrombotic events, including two patients with fatal pulmonary embolism; two other patients had bleeding severe enough to necessitate withdrawing the heparin. The cumulative event rate was 34.7% (95% CI, 13.7% to 55.2%). None of the patients treated with low-molecular-weight heparin had thrombosis or bleeding (CI, 0% to 14%). The difference between the two groups was significant (P = 0.006, log-rank test).

Conclusions: Low-molecular-weight heparin is safe and effective in the prevention of thromboembolism in selected patients with spinal cord injury and complete motor paralysis, and is superior to standard heparin in fixed doses of 5000 units three times a day.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)